Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

chemoradiotherapy

  • You have access
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation
    RYO TOYA, TAKAHIRO WATAKABE, DAIZO MURAKAMI, TOMOHIKO MATSUYAMA, TETSUO SAITO, YOSHIYUKI FUKUGAWA, KOHEI NISHIMOTO, YORIHISA ORITA and NATSUO OYA
    Anticancer Research January 2022, 42 (1) 205-209; DOI: https://doi.org/10.21873/anticanres.15474
  • You have access
    Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer
    MASAYUKI FUJIWARA, HIROSHI DOI, MASATAKA IGETA, HITOMI SUZUKI, KAZUHIRO KITAJIMA, MASAO TANOOKA, TOSHIHISA ISHIDA, TSUKASA WAKAYAMA, TAKASHI YOKOI, KOZO KURIBAYASHI, TAKASHI KIJIMA, MASAKI HASHIMOTO, NOBUYUKI KONDO, SEIJI MATSUMOTO, SEIKI HASEGAWA, NORIHIKO KAMIKONYA and KOICHIRO YAMAKADO
    Anticancer Research November 2021, 41 (11) 5793-5802; DOI: https://doi.org/10.21873/anticanres.15396
  • You have access
    Proton Beam Therapy for Local Recurrence of Rectal Cancer
    YUICHI HIROSHIMA, HITOSHI ISHIKAWA, MOTOHIRO MURAKAMI, MASATOSHI NAKAMURA, SHOSEI SHIMIZU, TSUYOSHI ENOMOTO, TATSUYA ODA, MASASHI MIZUMOTO, KEI NAKAI, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI
    Anticancer Research July 2021, 41 (7) 3589-3595; DOI: https://doi.org/10.21873/anticanres.15147
  • You have access
    The INCH Trial – Induction Chemotherapy in Patients With Bulky Anal Canal Cancer: Evaluation of the Pilot Phase
    FRANCESCA DE FELICE, ALESSIA FALLARINO, FRANCO IAFRATE, VERONICA MAIURI, GIOVANNI GALLONI, GIOVANNI TURRIZIANI COLONNA, RAFFAELLA DE PIETRO, GIUSEPPINA CHIARELLO, CLAUDIA MARCHETTI, NADIA BULZONETTI, DANIELA MUSIO and VINCENZO TOMBOLINI
    Anticancer Research June 2021, 41 (6) 3187-3191; DOI: https://doi.org/10.21873/anticanres.15105
  • You have access
    Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-RT) vs. Cisplatin and 5-Fluorouracil (CF-RT) for Patients With Unresectable Locally Advanced Esophageal Cancer in a Real-world Clinical Setting
    MAKOTO SAKAI, MAKOTO SOHDA, HIDEYUKI SAITO, NOBUHIRO NAKAZAWA, YASUNARI UBUKATA, KENGO KURIYAMA, KEIGO HARA, AKIHIKO SANO, HIROOMI OGAWA, TAKEHIKO YOKOBORI, KAZUTOSHI MURATA, SHIN-EI NODA, TATSUYA OHNO, KEN SHIRABE and HIROSHI SAEKI
    Anticancer Research April 2021, 41 (4) 2141-2145; DOI: https://doi.org/10.21873/anticanres.14986
  • You have access
    Chemoradiotherapy in Cancer Treatment: Rationale and Clinical Applications
    KATHRINE S. RALLIS, THOMAS HO LAI YAU and MICHAIL SIDERIS
    Anticancer Research January 2021, 41 (1) 1-7; DOI: https://doi.org/10.21873/anticanres.14746
  • You have access
    Bladder-conserving Approach in Radical Treatment of Patients With Bladder Cancer – A Single-institution Experience
    WOJCIECH MAJEWSKI, JAROSLAW NIECKULA, TOMASZ DWORZECKI and LESZEK MISZCZYK
    Anticancer Research October 2020, 40 (10) 5861-5868; DOI: https://doi.org/10.21873/anticanres.14605
  • You have access
    Fibrosis or Necrosis in Resected Lymph Node Indicate Metastasis Before Chemoradiotherapy in Lung Cancer Patients
    YUTA TAKAHASHI, JUNICHI SOH, KAZUHIKO SHIEN, HIROMASA YAMAMOTO, MASAOMI YAMANE, KATSUYUKI KIURA, SUSUMU KANAZAWA, HIROYUKI YANAI and SHINICHI TOYOOKA
    Anticancer Research August 2020, 40 (8) 4419-4423; DOI: https://doi.org/10.21873/anticanres.14447
  • You have access
    Surgical Versus Conservative Treatment for Endometrial Cancer in Women of Reproductive Age: Incidence of Urinary Tract Symptoms
    ANTONIOS KOUTRAS, ANGELIS PETEINARIS, SPYRIDON DAVAKIS, GEORGIOS KALINTERAKIS, IOANNIS TSILIKIS, NIKOLAOS GARMPIS, PROKOPIS-ANDREAS ZOTOS, ATHANASIOS CHIONIS, DIMITRIOS SCHIZAS, IOANNIS KARAVOKYROS, NIKOLAOS THOMAKOS, EMMANUEL KONTOMANOLIS and ATHANASIOS SYLLAIOS
    Anticancer Research June 2020, 40 (6) 3065-3069; DOI: https://doi.org/10.21873/anticanres.14287
  • You have access
    Phase II Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Unresectable Esophageal Cancer
    KOSUKE TAKAHASHI, YOSHIAKI OSAKA, YOSHIHIRO OTA, TAKAFUMI WATANABE, KENICHI IWASAKI, SHINGO TACHIBANA, YUICHI NAGAKAWA, KENJI KATSUMATA and AKIHIKO TSUCHIDA
    Anticancer Research May 2020, 40 (5) 2827-2832; DOI: https://doi.org/10.21873/anticanres.14256

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire